Hideki Garren - Net Worth and Insider Trading

Hideki Garren Net Worth

The estimated net worth of Hideki Garren is at least $16,420 dollars as of 2024-05-13. Hideki Garren is the Director of Coya Therapeutics Inc and owns about 2,000 shares of Coya Therapeutics Inc (COYA) stock worth over $16,420. Hideki Garren is also the Chief Medical Officer of Prothena Corp PLC and owns about 0 shares of Prothena Corp PLC (PRTA) stock worth over $0. Details can be seen in Hideki Garren's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Hideki Garren has not made any transactions after 2023-09-13 and currently still holds the listed stock(s).

Transaction Summary of Hideki Garren

To

Hideki Garren Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Hideki Garren owns 2 companies in total, including Prothena Corp PLC (PRTA) , and Coya Therapeutics Inc (COYA) .

Click here to see the complete history of Hideki Garren’s form 4 insider trades.

Insider Ownership Summary of Hideki Garren

Ticker Comapny Transaction Date Type of Owner
PRTA Prothena Corp PLC 2023-09-13 Chief Medical Officer
COYA Coya Therapeutics Inc 2023-01-03 director

Hideki Garren Latest Holdings Summary

Hideki Garren currently owns a total of 2 stocks. Among these stocks, Hideki Garren owns 2,000 shares of Coya Therapeutics Inc (COYA) as of January 3, 2023, with a value of $16,420 and a weighting of 100%. Hideki Garren also owns 0 shares of Prothena Corp PLC (PRTA) as of September 13, 2023, with a value of $0 and a weighting of 0%.

Latest Holdings of Hideki Garren

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
COYA Coya Therapeutics Inc 2023-01-03 2,000 8.21 16,420
PRTA Prothena Corp PLC 2023-09-13 0 21.34 0

Holding Weightings of Hideki Garren


Hideki Garren Form 4 Trading Tracker

According to the SEC Form 4 filings, Hideki Garren has made a total of 1 transactions in Coya Therapeutics Inc (COYA) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Coya Therapeutics Inc is the acquisition of 2,000 shares on January 3, 2023, which cost Hideki Garren around $9,300.

According to the SEC Form 4 filings, Hideki Garren has made a total of 12 transactions in Prothena Corp PLC (PRTA) over the past 5 years, including 0 buys and 12 sells. The most-recent trade in Prothena Corp PLC is the sale of 2,000 shares on September 13, 2023, which brought Hideki Garren around $110,960.

Insider Trading History of Hideki Garren

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Hideki Garren Trading Performance

GuruFocus tracks the stock performance after each of Hideki Garren's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Hideki Garren is -12.9%. GuruFocus also compares Hideki Garren's trading performance to market benchmark return within the same time period. The performance of stocks bought by Hideki Garren within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Hideki Garren's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Hideki Garren

Average Return

Average return per transaction

Outperforming Transactions

1 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -14.19
Relative Return to S&P 500(%) -22.36

Hideki Garren Ownership Network

Ownership Network List of Hideki Garren

No Data

Ownership Network Relation of Hideki Garren


Hideki Garren Owned Company Details

What does Prothena Corp PLC do?

Who are the key executives at Prothena Corp PLC?

Hideki Garren is the Chief Medical Officer of Prothena Corp PLC. Other key executives at Prothena Corp PLC include See Remarks Karin L Walker , Chief Operating Officer Brandon S. Smith , and Chief Regulatory Officer Carol D. Karp .

Prothena Corp PLC (PRTA) Insider Trades Summary

Over the past 18 months, Hideki Garren made 7 insider transaction in Prothena Corp PLC (PRTA) with a net sale of 34,000. Other recent insider transactions involving Prothena Corp PLC (PRTA) include a net sale of 85,000 shares made by Karin L Walker , a net sale of 55,000 shares made by Michael J Malecek , and a net sale of 145,000 shares made by Tran Nguyen .

In summary, during the past 3 months, insiders sold 0 shares of Prothena Corp PLC (PRTA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 524,001 shares of Prothena Corp PLC (PRTA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 524,001 shares.

Prothena Corp PLC (PRTA)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Prothena Corp PLC Insider Transactions

No Available Data

Hideki Garren Mailing Address

Above is the net worth, insider trading, and ownership report for Hideki Garren. You might contact Hideki Garren via mailing address: C/o Prothena Biosciences Inc, 331 Oyster Point Boulevard, South San Francisco Ca 94080.

Discussions on Hideki Garren

No discussions yet.